| Commodity: |
Soyabean / Soybeans |
| Traits: |
Lepidoptera resistance |
| Name of product applicant: |
Monsanto Argentina S.A.I.C. |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
26/01/2018 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
|
| Summary of the safety assessment (food safety): |
• Inheritance studies conducted indicated that Mendelian segregation exists. • New expression proteins are expressed in low levels. • It is compositionally equivalent to its non-transgenic counterpart. • No evidence of similarity or homology was found with known toxic proteins. • There is no evidence of expression of known allergenic substances for the proteins expressed in the event. It is concluded that the event is substantially equivalent to its conventional counterpart, therefore, it is as safe and no less nutritious than conventional commercial varieties. |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
GMO commercial approvals in Argentina
GMO approvals for food/feed
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
Monsanto Australia Ltd |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
14/01/2016 |
| Scope of authorization: |
Food |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
OECD BioTrack Product Database
|
| Summary of the safety assessment (food safety): |
|
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
A1110 - Food derived from Insect-protected Soybean Line MON87751
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name): Food Standards Australia New Zealand
Contact person name: Gaya Subramaniam
Website:
Physical full address: Level 4, 15 Lancaster Place, Majura Park ACT 2609, Australia
Phone number: +61 2 6271 2222
Fax number: +61 2 6271 2278
Country introduction: Food Standards Australia New Zealand (FSANZ) is the regulatory agency responsible for the development of food standards in Australia and New Zealand. The main office (approximately 115 staff) is located in Canberra (in the Australian Capital Territory) and the smaller New Zealand office (approximately 10 staff) is located in Wellington on the North Island.
Useful links
Relevant documents
Stacked events: FSANZ does not:
- Separately assess food from stacked event lines where food from the GM parents has already been approved;
- Mandate notification of stacked events by developers;
- Notify the public of stacked event ‘approvals’;
- List food derived from stacked event lines in the Code, unless the stacked event line has been separately assessed as a single line e.g. Application A518: MXB-13 cotton (DAS-21023-5 x DAS-24236-5)
No separate approval or safety assessment is necessary for foods derived from a stacked GM line that is the result of traditional breeding between a number of GM parent lines for which food has already been approved. Food from the parent lines must be listed in the Australia New Zealand Food Standards Code. The parent lines may contain any number of different genes. If food from any of the GM parent lines has not been approved, then a full pre-market safety assessment of food from the stacked line must be undertaken.
No separate approval is required for food derived from a line that is the product of a GM line, for which food has been approved, crossed traditionally with a non-GM line.
Where a single line containing a number of genes has been produced as a result of direct gene technology methods (rather than traditional crossing) then food derived from the line must undergo a full pre-market safety assessment before approval can be given.
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant: Food Standards Australia New Zealand (FSANZ) (http://www.foodstandards.gov.au)
| Name of product applicant: |
Monsanto do Brasil Ltda. |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
28/06/2017 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
ISAAA
|
| Summary of the safety assessment (food safety): |
The studies carried out indicated that pleiotropic and epistatic effects were not observed in the morphological and agronomic character evaluation tests performed with soybean MON 87751 in Brazil in the harvest of 2013/2014. The agronomic characteristics of MON 87751 soybean were not altered in relation to Commercial varieties, except for the expression of the insect resistance characteristic, which was the objective of introducing the cry1A.105 and cry2Ab2 genes into the soybean genome.
The characteristic conferred by the introduction of the cry1A.105 and cry2Ab2 genes is not expected to provide any competitive advantage or greater aggressiveness to MON 87751 soybean, which would result in an invasive species. The insect resistance characteristic does not make the MON 87751 soybean a weed or invasive of natural habitats, since the reproductive and vegetative development characteristics of the soybean were not altered. The only advantage of soybeans MON 87751 is insect resistance. |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
The techniques that may be used for the detection of MON 87751 soybeans consist of: i) bioassays with the crop target pests showing the
Effectiveness provided by the Cry1A.105 and Cry2Ab2 proteins; Ii) PCR (Polymerase Chain Reaction) technique applied for the detection and identification of inserted DNA using primers specifically designed for these events. |
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
CTNBio
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
Not Applicable |
E-mail:
Organization/agency name (Full name): National Biosafety Technical Commission
Contact person name: Paulo Augusto Viana Barroso
Website:
Physical full address: SPO Area 5 Qd 3 Bl B S 10.1 Brasilia DF
Phone number: 556120335087
Fax number:
Country introduction: Brazil had the first biosafety law approved in 1995. After the identification of the need to improve the biosafety system of Brazilian genetically modified organisms, a new law was published. The Law 11.105 / 05 establishes a technical committee dedicated to the analysis of the safety aspects of genetically modified organisms and a council of ministers that is dedicated to the analysis of the socioeconomic aspects of the commercial release of genetically modified organisms. In this context, Brazil already has several commercial products that involve genetically modified organisms (plants, human and veterinary vaccines, microorganisms for fuel production) and products derived from new genetic modification techniques.
Useful links
Relevant documents
Stacked events: At the discretion of, and upon consultation with, CTNBio, a new analysis and issuance of technical opinion may be released on GMOs containing more than one event, combined through classic genetic improvement and which have been previously approved for commercial release by CTNBio
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant: Dr. Paulo Augusto Viana Barroso (President of national Biosafety Commission)
| Name of product applicant: |
Monsanto Canada Inc. |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
31/10/2014 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
BioTrack Product Database
|
| Summary of the safety assessment (food safety): |
Please see decision document weblinks |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
Novel Foods Decision Document
Novel Feeds Decision Document
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name): Health Canada
Contact person name: Neil Strand
Website:
Physical full address: 251 Sir Frederick Banting Driveway, Tunney's Pasture, PL 2204A1
Phone number: 613-946-1317
Fax number:
Country introduction: Federal responsibility for the regulations dealing with foods sold in Canada, including novel foods, is shared by Health Canada and the Canadian Food Inspection Agency (CFIA). Health Canada is responsible for establishing standards and policies governing the safety and nutritional quality of foods and developing labelling policies related to health and nutrition. The CFIA develops standards related to the packaging, labelling and advertising of foods, and handles all inspection and enforcement duties. The CFIA also has responsibility for the regulation of seeds, veterinary biologics, fertilizers and livestock feeds. More specifically, CFIA is responsible for the regulations and guidelines dealing with cultivating plants with novel traits and dealing with livestock feeds and for conducting the respective safety assessments, whereas Health Canada is responsible for the regulations and guidelines pertaining to novel foods and for conducting safety assessments of novel foods.
The mechanism by which Health Canada controls the sale of novel foods in Canada is the mandatory pre-market notification requirement as set out in Division 28 of Part B of the Food and Drug Regulations.
Manufacturers or importers are required under these regulations to submit information to Health Canada regarding the product in question so that a determination can be made with respect to the product's safety prior to sale. The safety criteria for the assessment of novel foods outlined in the current guidance document (i.e. Canadian Guidelines for the Safety Assessment of Novel Foods) were derived from internationally established scientific principles and guidelines developed through the work of the Organization for Economic Cooperation and Development (OECD), Food and Agriculture Organisation (FAO), World Health Organisation (WHO) and the Codex Alimentarius Commission. These guidelines provide for both the rigour and the flexibility required to determine the need for notification and to conduct the safety assessment of the broad range of food products being developed. This flexibility is needed to allow novel foods and food products to be assessed on a case-by-case basis and to take into consideration future scientific advances.
Useful links
Relevant documents
Stacked events: Food: Consistent with the definition of "novel food" in Division 28 of the Food and Drug Regulations, the progeny derived from the conventional breeding of approved genetically modified plants (one or both parents are genetically modified) would not be classified as a novel food unless some form of novelty was introduced into such progeny as a result of the cross, hence triggering the requirement for pre-market notification under Division 28. For example, notification may be required for modifications observed in the progeny that result in a change of existing characteristics of the plant that places those characteristics outside of the accepted range, or, that introduce new characteristics not previously observed in that plant (e.g. a major change has occurred in the expression levels of traits when stacked). In addition, the use of a wild species (interspecific cross) not having a history of safe use in the food supply in the development of a new plant line may also require notification to Health Canada. However, molecular stacks are considered new events and are considered to be notifiable as per Division 28. Feed:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant: Neil Strand, Section Head of Novel Foods
| Name of product applicant: |
Compañia Agricola S.A.S |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
06/02/2017 |
| Scope of authorization: |
Food |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
|
| Summary of the safety assessment (food safety): |
Based on the risk assessment, it can be concluded that the event shows the same risks as its conventional counterpart. Therefore the National Technical Biosafety Committee for GMO use exclusively in Health and human consumption (CTNSalud) recommends its authorization |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
Bayer West-Central Africa S.A. |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
15/02/2024 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
|
| Summary of the safety assessment (food safety): |
The Board of the NBA considered the recommendations from the Technical Advisory Committee (TAC) following the Committee's thorough evaluation of the applications submitted by the applicant using information available on:
i. the Biosafety Clearing House (BCH), which is a mechanism set up by the Cartagena
Protocol on Biosafety to facilitate the exchange of information on Living Modified
Organisms (LMOs) and assist the Parties to better comply with their obligations under the Protocol and to which Ghana is a Party,
ii. the Organisation for Economic Co-operation and Development (OECD) Biotrack Product Database,
iii. the Food and Agriculture Organisation of the United Nations (FAO) genetically modified foods platform.
The following considerations were evaluated:
a. development of the modified events including the molecular biology data that characterizes the genetic change.
b. proximate analyses; major constituents (fats, proteins, carbohydrates) and minor
constituents (minerals and vitamins);
c. composition of, and nutritional information (including anti-nutrients) on the GM products compared to their conventional counterparts;
d. the potential for causing allergic reactions.
e. microbiological and chemical safety of the event(s);
f. the potential for production of new toxins in the event(s); and,
g. the potential for any unintended or secondary effects. |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
3 years |
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
Monsanto Indonesia (PT. Branita Sandhini) |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
05/11/2018 |
| Scope of authorization: |
Food |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
|
| Summary of the safety assessment (food safety): |
Please refer to the link provided (in Indonesian) |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
Monsanto Company (USA) |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
12/10/2016 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
|
| Summary of the safety assessment (food safety): |
Please see the links below. |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name): Food Safety Commission Secretariat,Cabinet Office,
Contact person name: Ms Yuki Tomokuni
Website:
Physical full address:
Phone number:
Fax number:
Country introduction: Safety assessments of GM foods are mandatory under the Food Sanitation Law in Japan. The Ministry of Health, Labour, and Welfare (MHLW) legally imposes safety assessments of GM foods so that those that have not undergone safety assessments would not be distributed in the country. MHLW receives application and requests the Food Safety COmmission of Japan (FSCJ) to evaluate the safety of GM foods in terms of human health. Safety assessments are carried out by FSCJ.
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
Monsanto Malaysia Sdn. Bhd. |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
15/03/2021 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
Department of Biosafety Malaysia
CBD Biosafety Clearing House
|
| Summary of the safety assessment (food safety): |
Please refer to the Risk Assessment Report. |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name): Department of Biosafety Malaysia
Contact person name: Dr. Anita Anthonysamy
Website:
Physical full address: Department of Biosafety,
Ministry of Natural Resources and Environmental Sustainability
Level 4, Block F11, Complex F
Lebuh Perdana Timur, Precinct 1
62000 Putrajaya, Malaysia
Phone number: +60380917322
Fax number: +60380917371
Country introduction: GM food safety assessment is a requirement by law under the Biosafety Act 2007 in Malaysia. The National Biosafety Board reviews and makes decisions on events based on a scientific/technical risk assessment, policy considerations as well as public input. The decisions and its related documents made are publicly available through the Malaysian Department of Biosafety Website and the Convention of Biological Diversity Biosafety Clearing House.
Useful links
Relevant documents
Stacked events: One of the terms and conditions that will be imposed for every decision for Food Feed and Processing since the year 2024 is "Any import or release of products derived from any new genetically modified lines bred using [name of event, eg. MON94100 canola] will require a separate approval from the National Biosafety Board". This gives clear direction to the approved person that a stacked event will require a separate approval.
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant: Department of Biosafety, Ministry of Natural Resources and Environmental Sustainability, Level 4, Block F11, Complex F Lebuh Perdana Timur, Precinct 1 62000 Putrajaya, Malaysia. Email: [email protected]. Url: www. biosafety.gov.my
Food Safety and Quality Division, Ministry of Health, Level 4, Menara Prisma, No. 26, Persiaran Perdana, Putrajaya, Malaysia, 62675. Phone: +603 88850797 Fax: +603 88850790 Email: [email protected]
| Name of product applicant: |
Monsanto Comercial, S. de R. L. de C.V. |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
12/05/2016 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
|
| Summary of the safety assessment (food safety): |
No toxic, allergic or substantial nutritional changes were observed. Therefore it can be ensured that the Genetically Modified Soybean (Glycine max). OCDE identifier: MON-87751-7 is, based on the existing knowledge to date, as innocuous as its conventional counterpart. |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
Monsanto Australia Ltd |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
16/03/2016 |
| Scope of authorization: |
Food |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
OECD BioTrack Product Database
|
| Summary of the safety assessment (food safety): |
In conducting a safety assessment of food derived from MON87751, a number of criteria
have been addressed including: a characterisation of the transferred gene sequences, their origin, function and stability in the soybean genome; the changes at the level of DNA and protein in the whole food; compositional analyses; and evaluation of intended and unintended changes.
No potential public health and safety concerns have been identified in the assessment of
insect-protected soybean line MON87751. On the basis of the data provided in the present Application, and other available information, food derived from MON87751 is considered to be as safe for human consumption as food derived from conventional soybean varieties. |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
A1110 – Food derived from Insect-protected Soybean Line MON87751
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
MONSANTO |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
08/11/2019 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
MON-87751-7
|
| Summary of the safety assessment (food safety): |
The food and feed safety assessment was performed following the CODEX Guidelines. |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
Monsanto Philippines |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
03/09/2018 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
|
| Summary of the safety assessment (food safety): |
A. STRP, PPSSD, BAI (Safety Assessment)
After thorough review of the technical documents submitted by the applicant, the assessors’ findings were as follows:
1. Host Organism (Soybean)
Soybean is a source of key nutrients such as proteins carbohydrates, fats, minerals (calcium, phosphorous, potassium, magnesium, iron, sodium, selenium, manganese, copper and zinc) and vitamins (A and B complex, K and E). In the human diet, soybean is consumed as food as soy milk, milk curd/tofu, whole cooked seed, edible soybean oil along with other vegetable oils, among others. On the other hand, soybean meal is a source of protein in animal diet.
Soybean also contains several antinutrients such as heat labile trypsin inhibitors, lectins, stachyose, raffinose and phytic acid. Trypsin inhibitors activities are destroyed during toasting or heating whole soybean or meal while lecithin is readily inactivated by moist heat when raw soybean is processed into defatted, toasted soybean meal. Soybean meal contains stachyose and raffinose that cause flatulence in swine and poultry. However, these are reduced or decreased by processing soybean further into concentrates or isolates. For phytic acid, adding phytase into the diets of poultry and swine will release phytinbond phosphorus that decreased phytic acid in the diet.
Further, soybean is not a source of toxicants. Although, soybean contains recognized allergenic protein, but relevant estimate of its allergenic potential is not complete. There is no significant level of amino acid homology exists between the pat gene and any protein allergens.
2. Donor Organism (Bacillus thuringensis)
The donor organism, Bacillus thuringensis is not known to be toxic or allergenic or pathogenic to humans, animals or plants. Bioinformatics analyses showed that the CryA.105 and Cry2Ab2 proteins do not share structurally or immunologically relevant amino acid sequence similarities with known allergens and pathogens.
Further, as shown in simulated digestion experiments using simulated digestive fluids, CryA.105 and Cry2Ab2 are rapidly digested. Thus, these cry proteins are not similar to known allergens and do not pose significant allergenic risk to humans or animals.
The molecular characterization of MON 87751 by Next Generation Sequencing and Junction Sequence Analysis (NGS/JSA) showed that a single copy of the intended transfer DNA (T-DNA I) containing the crylA.105 and the cry2Ab2 expression cassettes from PV-GMIR13196 was integrated into the soybean genome at a single locus. These analyses also showed no PV-GMIR13196 backbone or T-DNA II elements had been inserted.
3. The Transformation System
Soybean MON87751 was genetically modified using Agrobacterium tumefaciens -mediated transformation of soybean tissue using the transformation plasmid vector PV-GMIR13196.
The plasmid vector PV GMIR13196 contains two separate T DNAs that are each delineated by left and right border regions. The first T DNA, designated as T DNA I, contains the crylA.105 and cry2Ab2 expression cassettes. The second T DNA, designated as T DNA II, contains marker genes that allow for simplified selection of transformed tissue. During transformation, both T DNAs were inserted into the soybean genome. Subsequently, traditional breeding, segregation, selection and screening were used to isolate those plants that contain the crylA.105 and cry2Ab2 expression cassettes (T DNA I) and results showed it do not contain the marker gene expression cassettes (T DNA II), resulting in the production of marker-free, MON 87751.
4. The Inserted DNA
Using a combination of sequencing, PCR and bioinformatics, MON87751 demonstrated to contain one copy of the intended transfer DNA (T-DNA I) containing the cryIa.105 and the cry2Ab2 expression cassettes stably integrated at a single locus and inherited according to Mendelian principles over multiple generations.
The sequence and organization of the DNA insert is identical to the corresponding region in the PV GMIR13196 T DNA I. This was determined through directed sequencing (locus-specific PCR, DNA sequencing and analyses) on MON 87751 which established the complete sequence of the single DNA insert from PV GMIR13196, the adjacent flanking DNA, and the 5' and 3' insert-to-flank junctions. Further, this also confirmed that no vector backbone, or T-DNA II, or other unintended plasmid sequences are present in MON 87751.
5. Genetic Stability
The Next Generation Sequencing and Junction Sequence Analysis (NGS/JSA) showed the stability of the DNA insert across multiple generations. Thus, MON87751 contains a single and stable T-DNA I insertion.
Chi square test analysis was done and showed the stability of the insert over three generations (F2, F3 and F4).
The segregation analyses showed the heritability and stability of the insert as expected across multiple generations substantiating the molecular insert stability analysis and established the genetic behavior of the T-DNA I in MON 87751 at a single chromosomal locus.
6. Expressed Material
Using the enzyme-linked immunosorbent assay (ELISA), the expression levels of proteins Cry1A.105 and Cry2Ab2 in various MON 87751 plant tissues at different growth stages such as leaf, root, forage and seed were determined. The mean concentrations of each protein in leaves, roots, forage, and seeds were provided below.
Cry1A.105
The mean Cry1A.105 protein levels are: 400-790 ug/g dwt in leaves, 230 ug/g dwt in forage, 2.4 ug/g dwt in seeds, 11ug/g dwt in pollen/anther and below the limit of detection in roots.
Cry2Ab2
The mean Cry2Ab2 protein levels are: 24-32ug/g dwt in leaves, 14ug/g dwt in forage, 15ug/g dwt in seeds, 7.7ug/g dwt in pollen/anther and 15ug/g dwt in roots.
7. Toxicological Assessment
Digestibility
Digestibility of Cry1A.105 and Cry2Ab2 proteins was evaluated in Simulated Gastric Fluids (SGF) and Simulated Intestinal Fluids (SIF) and was analyzed through the sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis.
Further, results showed that Cry1A.105 and Cry2Ab2 were rapidly digested at 0.5 minutes upon incubation in SGF with pepsin and in SIF with pancreatinin.
Heat Inactivation
Results of analyses showed that an increase in temperature did not affect the band intensity of Cry1A.105 and Cry2Ab2 proteins in SDS-PAGE. While the functional activity of Cry1A.105 and Cry2Ab2 proteins were decreased upon heat treatment at 75C and 55C, respectively for 15 and 30 minutes.
Amino Acid Comparison
Results of the FASTA bioinformatic alignment search showed that neither of the proteins (Cry1A.105 and Cry2Ab2) is homologous with known toxins.
Acute Oral Gavage
Cry1A.105 protein administered by oral gavage at a total dose of 2072 mg/kg body weight and Cry2Ab2 administered at a total dose of 2198 mg/kg body weight of CD-1 mice showed no treatment-related effects on survival, clinical observations, body weight gain, food consumption or gross pathology.
Source of Test Protein
The Cry1A.105 and Cry2Ab2 proteins were produced in Escherichia coli.
SDS-PAGE and Western blot analysis showed that the microbiologically-produced and the MON 87751 soybean expressed proteins were equivalent in terms of molecular weight and immune recognition.
Compositional Analysis (Nutritional Data)
Proximate Analysis
No statistically significant differences were observed in the proximate levels (moisture, protein, fat, ash, carbohydrates, acid detergent fiber (ADF) and neutral detergent fiber (NDF) between the test soybean and the control soybean.
Vitamins and Mineral Composition, Amino acids, Fatty Acids
A significant difference was observed in the levels of seven (7) nutrient components (protein, glycine, proline, phosphorus and vitamin E in seed and total fat and NDF in forage) out of the 50 components assessed for MON87751. However, the mean difference of these 7 components between MON87751 and control was less than the conventional control range value. Further, the MON 87751 mean component values were within the values observed in ILSI Crop Composition Database values.
Anti-nutrients
(lectin, trypsin inhibitors, phytic acid, raffinose and stachyose)
No significant differences were observed for lectin, trypsin inhibitors, phyticacid, and stachyose. A statistically significant difference (p<0.05) was observed for raffinose. The mean difference in raffinose values between MON 87751 and the conventional control was less than the range of the conventional control values, indicating that MON 87751 does not impact levels of raffinose more than natural variation within the conventional control grown at multiple locations.
|
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
September 4, 2023 |
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
Monsanto Korea Ltd. |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
05/07/2017 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
|
| Summary of the safety assessment (food safety): |
Please see the link below(in Korean). |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name): Ministry of Food and Drug Safety
Contact person name:
Website:
Physical full address: Osong Health Technology Administration Complex, 187, Osongsaengmyeong 2-ro, Osong-eup, Cheongwon-gun, Chungcheonbuk-do, 363-700, Korea
Phone number: 82-43-719-2360
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
Monsanto |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
08/05/2019 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
|
| Summary of the safety assessment (food safety): |
MON87751-7 has been modified to be protected against lepidopteran pests. Protection against these pests is achieved through expression of Cry1A.105 and Cry2Ab2, encoded by the cry1A.105 and cry 2Ab2 genes, respectively, derived from Bacillus thuringiensis. The Cry1A.105 protein is chimeric and comprises functional domains derived from the Cry1Ab, Cry1F and Cry1Ac proteins. The safety of the Cry1A.105 and Cry2Ab2 proteins has previously been assessed.
Molecular analyses showed that there is a single insertion site comprising a single, complete copy of each of the two expression cassettes. The introduced genetic elements are stably inherited from one generation to the next generation. There are no antibiotic resistance marker genes present in the line and no plasmid backbone has been incorporated into the transgenic locus.
Soybean MON87751-7 contains two newly expressed proteins, Cry1A.105 and Cry2Ab2, which are unlikely to be toxic or allergenic in humans.
Compositional analyses concluded that seeds from MON87751-7 are compositionally equivalent to seeds from conventional soybean varieties.
Based on the data provided in the present application, and other available information, food derived from MON87751-7 is considered to be as safe as food derived from conventional soybean varieties. |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
Monsanto Company |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
27/04/2015 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
|
| Summary of the safety assessment (food safety): |
Please consult the website links below. |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
FDA's webpage regarding this variety
EPA Registered Plant Incorporated Protectants
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
| Name of product applicant: |
BAYER S.A |
| Summary of application: |
|
| Upload: |
|
| Date of authorization: |
05/11/2021 |
| Scope of authorization: |
Food and feed |
| Links to the information on the same product in other databases maintained by relevant international organizations, as appropriate. (We recommend providing links to only those databases to which your country has officially contributed.): |
BCH
|
| Summary of the safety assessment (food safety): |
Please refer to uploaded document |
| Upload: |
|
| Where detection method protocols and appropriate reference material (non-viable, or in certain circumstances, viable) suitable for low-level situation may be obtained: |
|
| Relevant links to documents and information prepared by the competent authority responsible for the safety assessment: |
SNB
|
| Upload: |
|
| Authorization expiration date (a blank field means there is no expiration date) |
|
E-mail:
Organization/agency name (Full name):
Contact person name:
Website:
Physical full address:
Phone number:
Fax number:
Country introduction:
Useful links
Relevant documents
Stacked events:
Contact details of the competent authority(s) responsible for the safety assessment and the product applicant:
|
|